Literature DB >> 14047546

EXPERIMENTAL PANCREATITIS: USE OF A NEW ANTIPROTEOLYTIC SUBSTANCE, TRASYLOL.

A D MCCUTCHEON.   

Abstract

Keywords:  DOGS; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; PANCREATITIS; PEPTIDE HYDROLASES

Mesh：

Substances：

Year:  1963        PMID： 14047546      PMCID： PMC1408520          DOI： 10.1097/00000658-196308000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  19 in total

1.  Significance of vascular injury as a factor in the pathogenesis of pancreatitis.

Authors:  M C ANDERSON; J J BERGAN
Journal:  Ann Surg       Date:  1961-07       Impact factor: 12.969

2.  The use of human serum albumin in the management of acute pancreatitis; experimental and clinical observations.

Authors:  D W ELLIOTT; R M ZOLLINGER; R MOORE; E H ELLISON
Journal:  Gastroenterology       Date:  1955-04       Impact factor: 22.682

3.  Retardation of the progress of experimental pancreatitis with trypsin inhibitors.

Authors:  R H CANNON; M D TURNER
Journal:  Surg Forum       Date:  1961

4.  Acute haemorrhagic (gangrenous) pancreatitis: experimental data supporting the vascular phenomenon in its pathogenesis.

Authors:  J W HINTON
Journal:  J R Coll Surg Edinb       Date:  1962-01

5.  Twenty-five years' experience with pancreatitis.

Authors:  J G PROBSTEIN; H T BLUMENTHAL
Journal:  Am J Gastroenterol       Date:  1961-06       Impact factor: 10.864

6.  Physiology of the human pancreas.

Authors:  H DOUBILET
Journal:  Surg Gynecol Obstet       Date:  1958-07

7.  Experimental study of interstitial injection of trypsin and trypsinogen into the pancreas.

Authors:  L M KEITH; J E BARNES; F R DENKEWALTER
Journal:  AMA Arch Surg       Date:  1958-09

8.  Serum trypsin determination in pancreatic disease.

Authors:  G L NARDI
Journal:  J Lab Clin Med       Date:  1958-07

9.  Acute hemorrhagic pancreatitis: a safe, effective technique for diagnostic paracentesis.

Authors:  R B PFEFFER; G MIXTER; J W HINTON
Journal:  Surgery       Date:  1958-04       Impact factor: 3.982

10.  Experimental Pancreatitis A Possible Etiology of Postoperative Pancreatitis.

Authors:  A D McCutcheon; D Race
Journal:  Ann Surg       Date:  1962-04       Impact factor: 12.969
View more
  12 in total

Review 1.  RECENT ADVANCES IN THE TREATMENT OF SURGICAL EMERGENCIES.

Authors:  W SILEN
Journal:  Calif Med       Date:  1964-08

2.  EXPERIMENTAL FAT NECROSIS: EFFECT OF TRASYLOL. IMPLICATIONS FOR PANCREATITIS.

Authors:  A D MCCUTCHEON; D RACE
Journal:  Ann Surg       Date:  1964-12       Impact factor: 12.969

3.  [STUDIES ON THE EFFECTS OF A TRYPSIN INHIBITOR (TRASYLOL) ON ENZYME ACTIVITIES AND MORPHOLOGY IN TAUROCHOLATE AND CALCIPHYLAXIS PANCREATITIS OF THE RAT (A CONTRIBUTION TO THE PATHOGENESIS OF PANCREATITIS. II.)].

Authors:  W CREUTZFELDT; H SCHMIDT; I HORBACH
Journal:  Klin Wochenschr       Date:  1965-01-01

4.  TREATMENT OF ACUTE PANCREATITIS WITH TRASYLOL: REPORT OF A CONTROLLED THERAPEUTIC TRIAL.

Authors:  A SKYRING; A SINGER; P TORNYA
Journal:  Br Med J       Date:  1965-09-11

5.  Trasylol.

Authors: 
Journal:  Br Med J       Date:  1966-12-24

Review 6.  Is there a place for proteinase inhibition? A review of the literature.

Authors:  G D Lister
Journal:  Postgrad Med J       Date:  1969-08       Impact factor: 2.401

7.  Trasylol in acute pancreatitis.

Authors:  J E Trapnell; C H Talbot; W M Capper
Journal:  Am J Dig Dis       Date:  1967-04

8.  Protease inhibitors and experimental acute hemorrhagic pancreatitis.

Authors:  T Manabe; M L Steer
Journal:  Ann Surg       Date:  1979-07       Impact factor: 12.969

9.  Estimation of plasma esterolytic activity and its in vitro inhibition by proteinase inhibitors during acute pancreatitis in the human.

Authors:  K J Worthington; A Cuschieri
Journal:  Br J Exp Pathol       Date:  1976-04

10.  Failure of trasylol to reduce intestinal content of trypsin and chymotrypsin in man.

Authors:  D M Goldberg; R Campbell; A D Roy
Journal:  Gut       Date:  1970-08       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.